A detailed history of Occudo Quantitative Strategies LP transactions in Savara Inc stock. As of the latest transaction made, Occudo Quantitative Strategies LP holds 92,521 shares of SVRA stock, worth $279,413. This represents 0.08% of its overall portfolio holdings.

Number of Shares
92,521
Previous 36,274 155.06%
Holding current value
$279,413
Previous $146,000 168.49%
% of portfolio
0.08%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.96 - $5.07 $222,738 - $285,172
56,247 Added 155.06%
92,521 $392,000
Q2 2024

Aug 14, 2024

BUY
$3.66 - $5.34 $132,762 - $193,703
36,274 New
36,274 $146,000

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $344M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.